The chemical substance with the name "[(4S,7aR)-1-[(1S,2R)-2-hydroxy-5-(methoxymethoxy)-1,5-dimethyl-hex-3-ynyl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-yl] benzoate" and CAS number "100937-69-7" is a complex organic compound characterized by its multi-ring structure and various functional groups. It features a benzoate moiety, indicating the presence of a benzoic acid derivative, which contributes to its potential biological activity. The stereochemistry is significant, as indicated by the specific configurations at multiple chiral centers, which can influence the compound's interactions in biological systems. The presence of hydroxy and methoxy groups suggests potential for hydrogen bonding and increased solubility in polar solvents. This compound may exhibit pharmacological properties, making it of interest in medicinal chemistry and drug development. Its intricate structure and stereochemistry could also imply specific reactivity patterns and interactions with biological targets, warranting further investigation into its potential applications.

[(4S,7aR)-1-[(1S,2R)-2-hydroxy-5-(methoxymethoxy)-1,5-dimethyl-hex-3-ynyl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-yl] benzoate

100937-69-7: The chemical substance with the name "[(4S,7aR)-1-[(1S,2R)-2-hydroxy-5-(methoxymethoxy)-1,5-dimethyl-hex-3-ynyl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-yl] benzoate" and CAS number "100937-69-7" is a complex organic compound characterized by its multi-ring structure and various functional groups. It features a benzoate moiety, indicating the presence of a benzoic acid derivative, which contributes to its potential biological activity. The stereochemistry is significant, as indicated by the specific configurations at multiple chiral centers, which can influence the compound's interactions in biological systems. The presence of hydroxy and methoxy groups suggests potential for hydrogen bonding and increased solubility in polar solvents. This compound may exhibit pharmacological properties, making it of interest in medicinal chemistry and drug development. Its intricate structure and stereochemistry could also imply specific reactivity patterns and interactions with biological targets, warranting further investigation into its potential applications.

CAS 100937-69-7

[(4S,7aR)-1-[(1S,2R)-2-hydroxy-5-(methoxymethoxy)-1,5-dimethyl-hex-3-ynyl]-7a-methyl-1,2,3,3a,4,5,6,7-octahydroinden-4-yl] benzoate